moderately hypofractionated radiotherapy

RADIATION2 trials

Sponsors

Shanghai Zhongshan Hospital, Fudan University

Conditions

Moderately Hypofractionated RadiotherapyRectal CancerSerplulimabpMMR/MSS

Phase 2

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Not yet recruitingNCT06599827

Shanghai Zhongshan HospitalRectal Cancer

Start: 2024-09-20End: 2029-09-20Target: 54Updated: 2024-09-19

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

Not yet recruitingNCT07527520

Fudan UniversityModerately Hypofractionated Radiotherapy, pMMR/MSS, Rectal Cancer +1

Start: 2026-06-01End: 2031-06-01Target: 165Updated: 2026-04-14